COPART Risk Score Predicts Long-term Mortality in Peripheral XXXX .

@entity1 @entity432 @entity583 @entity204 @entity6817 @entity1851
OBJECTIVES: The COhorte de @entity1 ART  riopathes (COPART) Risk Score is a risk score assessing the 1 year outcome of @entity1 who received inpatient treatment because of their peripheral @entity432 (PAOD). The COPART Risk Score consists of six variables each of which is allocated a different number of points (age, history of @entity583 , @entity1851 , ankle-brachial index, estimated glomerular filtration rate, medication with antiplatelet agents, @entity6817 and renin-angiotensin system inhibitors). METHODS: 129 consecutive claudicants were included in a prospective trial with an average follow up of 8.8 (   0.7) years. All @entity1 were hospitalized for their first endovascular procedure to the pelvic and/or femoropopliteal arteries. The endpoints were all cause mortality and cardiovascular (CV) @entity204 . The COPART Risk Score was calculated for the three @entity1 cohorts (low risk: 52 @entity1 [40.3%]; medium risk: 41 @entity1 [31.8%]; high risk: 36 @entity1 [27.9%]). RESULTS: During the follow up period 23.1% (n  =  12) of @entity1 in the low risk group, 34.1% (n  =  14) of @entity1 in the medium risk group, and 63.9% (n  =  23) of @entity1 in the high risk group died. CV @entity204 occurred in 11.5% in the low, 22.0% in the medium, and 41.7% in the high risk groups. The three groups differed significantly with regard to all cause and CV mortality (p  <  .0001 and p  =  .001). CONCLUSIONS: The COPART Risk Score is a suitable instrument to predict long-term all cause and CV mortality in claudicants preceding their first peripheral intervention.
